Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PTO to publish new rules

The U.S. PTO announced that it will publish new rules limiting the number of continuations and claims allowed

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE